Brain potential changes after intranasal vs. intravenous administration of vasopressin: Evidence for a direct nose-brain pathway for peptide effects in humans

Biological Psychiatry

Volumn 39, Issue 5, 1996, Pages 332-340

  Pietrowsky, Reinhard ^a   Strüben, Christel ^a   Mölle, Matthias ^a   Fehm, Horst L ^a   Born, Jan ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Arginine vasopressin; Event related potentials (ERPs); Human; Nose brain pathway; P3

Indexed keywords

ARGIPRESSIN; PLACEBO; VASOPRESSIN;

ADULT; ARTICLE; BLOOD PRESSURE; BRAIN FUNCTION; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; EVOKED RESPONSE; HUMAN; HUMAN EXPERIMENT; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TASK PERFORMANCE; VOLUNTEER;

EID: 0343961971     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00180-8     Document Type: Article

References (25)

1. Baker H, Spencer RF (1986): Transneural transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp Brain Res 63:461-473.
2. Balin BJ, Broadwell RD, Salcman M, El-Kalliny M (1986): Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J Comp Neurol 251:260-280.
3. Born J, Bothor R, Pietrowsky R, Fehm-Wolfsdorf G, Pauschinger P, Fehm HL (1987): Influences of vasopressin and oxytocin on human event-related brain potentials in an attention task. J Psychophysiol 1:351-360.
4. Born J, Fehm HL (1988): The hormonal modulation of stimulus processing in humans. German J Psychol 12:315-331.
5. Born J, Fehm-Wolfsdorf G, Lutzenberger W, Voigt KH, Fehm HL (1986): Vasopressin and electrophysiological signs of attention in man. Peptides 7:189-193.
6. Born J, Kellner C, Uthgenannt U, Kern W, Fehm HL (1991): Vasopressin regulates human sleep by reducing rapid-eye movement sleep. Am J Physiol 262:E295-E300.
7. Broadwell RD, Balin BJ (1985): Endocytic and exocytic pathway of the neuronal secretory process and trans-synaptic transfer of wheat germ agglutinin-horseradish peroxidase in vivo. J Comp Neurol 242:632-650.
8. Burbach JPH, Kovacs GL, De Wied D, Van Nispen JW, Greven HM (1983): A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide. Science 221:1310-1312.
9. Dahl AR, Hadley WM (1991): Nasal cavity enzymes involved in xenobiotic metabolism effects on the toxicity of inhalants. Crit Rev Toxicol 21:345-372.
10. Donchin E, Coles MGH (1988): Is the P300 component a manifestation of context updating? Behav Brain Sci 11:357-374.
11. Fehm-Wolfsdorf G, Bachholz G, Born J, Voigt KH, Fehm HL (1988): Vasopressin but not oxytocin enhances cortical arousal: An integrative hypothesis on behavioral effects on neurohypophyseal hormones. Psychopharmacology 94:496-500.
12. Fehm-Wolfsdorf G, Born J (1991): Behavioral effects of neurohypophyseal peptides in healthy volunteers: 10 years of research. Peptides 12:1399-1406.
13. Fehm-Wolfsdorf G, Born J, Voigt KH, Fehm HL (1984): Behavioral effects of vasopressin. A single case study. Neuropsychobiology 11:49-53.
14. Itaya SK (1987): Anterograde transsynaptic transport of WGA-HRP in rat olfactory pathways. Brain Res 409:205-214.
15. Johnston VS, Wang XT (1991): The relationship between menstrual phase and P3 component of ERPs. Psychophysiology 28:400-409.
16. Klorman R, Brumaghim JT (1991): Stimulant drugs and ERPs. In Brunia CHM, Mulder G, Verbaten MN (eds), Even-related Brain Research, EEG suppl 41. Amsterdam: Elsevier, pp 135-141.
17. Le Moal M, Koob GF, Koda LH, et al (1981): Vasopressin receptor antagonist prevents behavioral effects of vasopressin. Nature 291:491-493.
18. Loup F, Tribollet E, Dubois-Dauphin M, Dreifuss JJ (1991): Localization of high-affinity binding sites of oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Res 555:220-232.
19. Näätänen R, Picton TW (1987): The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure. Psychophysiology 24: 375-425.
20. Naumann E, Bartussek D, Kaiser W, Fehm-Wolfsdorf G (1991): Vasopressin and cognitive processes: Two event-related potential studies. Peptides 12:1379-1384.
21. Pietrowsky R, Born J, Fehm-Wolfsdorf G, Fehm HL (1989): The influence of a vasopressin-analog (DGAVP) on event-related potentials in a stimulus-mismatch paradigm. Biol Psychol 28:239-250.
22. Sahgal A (1984): A critique of the vasopressin-memory hypothesis. Psychopharmacology 83:215-228.
23. Timsit-Berthier M, Mantanus H, Devos JE, Spiegel R (1982): Action of lysine-vasopressin on human electroencephalographic activity. Neuropsychobiology 8:248-258.
24. Verleger R (1988): Event-related potentials and cognition: A critique of the context updating hypothesis and an alternative interpretation of the P3. Behav Brain Sci 11:343-356.
25. Zlokovic BV, Segal MB, Davson H, Lipovac MN, Hyman S, McComb JG (1990): Circulating neuroactive peptides and the blood brain and blood cerebrospinal fluid barrier. Endocrinol Exp 24:9-17.